Chronological development of in-patient oncology in times of COVID-19: a retrospective analysis of hospitalized oncology and COVID-19 patients of a German University Hospital

[1]  M. Kochańczyk,et al.  The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion , 2022, Viruses.

[2]  P. Dasgupta,et al.  Impact of the COVID‐19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan , 2022, BJUI compass.

[3]  L. Jacob,et al.  Decrease in the number of patients diagnosed with cancer during the COVID-19 pandemic in Germany , 2022, Journal of Cancer Research and Clinical Oncology.

[4]  T. Zhou,et al.  Neutralization and Stability of SARS-CoV-2 Omicron Variant , 2021, bioRxiv.

[5]  Сергій Серік,et al.  РІВНІ МОНОЦИТАРНОГО ХЕМОАТРАКТАНТНОГО ПРОТЕЇНУ-1 У ХВОРИХ НА ЦУКРОВИЙ ДІАБЕТ 2 ТИПУ У ПОЄДНАННІ З ІШЕМІЧНОЮ ХВОРОБОЮ СЕРЦЯ , 2021, Problems of Endocrine Pathology.

[6]  T. Burki.  Omicron variant and booster COVID-19 vaccines , 2021, The Lancet Respiratory Medicine.

[7]  R. Wilkinson,et al.  Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy , 2021, medRxiv.

[8]  Kang Zhang,et al.  The challenges of COVID‐19 Delta variant: Prevention and vaccine development , 2021, MedComm.

[9]  C. Scheidel,et al.  Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis. , 2021, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

[10]  Dinh Q. Phung,et al.  Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study , 2021, The Lancet Oncology.

[11]  M. Gerken,et al.  The Impact of the COVID-19 Pandemic on Cancer Incidence and Treatment by Cancer Stage in Bavaria, Germany. , 2021, Deutsches Arzteblatt international.

[12]  Rajesh K. Gupta,et al.  Greater Covid-19 Severity and Mortality in Hospitalized Patients in Second (Delta Variant) Wave Compared to the First: Single Centre Prospective Study in India , 2021, medRxiv.

[13]  A. Nakajima,et al.  Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan , 2021, JAMA network open.

[14]  J. Hidary,et al.  Morbidity and mortality from COVID-19 post-vaccination breakthrough infections in association with vaccines and the emergence of variants in Bahrain , 2021 .

[15]  M. Schrappe,et al.  Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: Evidence from the German Childhood Cancer Registry and a qualitative survey , 2021, The Lancet Regional Health - Europe.

[16]  D. Miglioretti,et al.  Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling , 2021, Journal of the National Cancer Institute.

[17]  E. Alba,et al.  Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study , 2021, Cancers.

[18]  H. De Schutter,et al.  Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis , 2021, ESMO open.

[19]  V. Vardhanabhuti,et al.  Differential Impact of COVID-19 on Cancer Diagnostic Services Based on Body Regions: A Public Facility-Based Study in Hong Kong , 2021, International Journal of Radiation Oncology*Biology*Physics.

[20]  P. De Luca,et al.  Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect? , 2021, European Archives of Oto-Rhino-Laryngology.

[21]  D. Sarfati,et al.  The impact of the COVID-19 pandemic on cancer diagnosis and service access in New Zealand–a country pursuing COVID-19 elimination , 2021, The Lancet Regional Health - Western Pacific.

[22]  T. Luedde,et al.  Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany , 2021, Cancers.

[23]  Q. Meng,et al.  Are overwhelmed health systems an inevitable consequence of covid-19? Experiences from China, Thailand, and New York State , 2021, BMJ.

[24]  A. Stang,et al.  Drop in Cancer Reporting by Pathologists in North Rhine-Westphalia, Germany, During the COVID-19 Lockdown. , 2020, Deutsches Arzteblatt international.

[25]  A. Bollmann,et al.  Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic , 2020, Oncology Research and Treatment.

[26]  D. Patt,et al.  Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors , 2020, JCO clinical cancer informatics.

[27]  C. Singer,et al.  Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective , 2020, International Journal of Gynecological Cancer.

[28]  Kristy L Marynak,et al.  Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[29]  P. Lovat,et al.  Reduction in skin cancer diagnoses in the UK during the COVID‐19 pandemic , 2020, Clinical and experimental dermatology.

[30]  C. Griffiths,et al.  Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID‐19 pandemic , 2020, The British journal of dermatology.

[31]  G. Trobia,et al.  Delayed access or provision of care in Italy resulting from fear of COVID-19 , 2020, The Lancet Child & Adolescent Health.

[32]  J. Fernando.  THE EFFECT OF COVID-19 , 2023 .

[33]  J. Dushoff,et al.  Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa 2021-12-01 , 2021 .

[34]  Y. Omuro,et al.  [Gastrointestinal cancer]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.